B' Hadley Wilson, MD, FACC

1
Percutaneous Valvuloplasty
B. Hadley Wilson, MD, FACC
The Sanger Clinic, PA October 26, 2004

2
B. Hadley Wilson, MD, FACC

• Disclosure Information
• The following relationships exist
• Consultant BSC, Cordis
• Off label use of products will be discussed
  in this presentation

3
(No Transcript)
4
(No Transcript)
5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
(No Transcript)
9
(No Transcript)
10
(No Transcript)
11
(No Transcript)
12
(No Transcript)
13
(No Transcript)
14
(No Transcript)
15
(No Transcript)
16
(No Transcript)
17
(No Transcript)
18
(No Transcript)
19
(No Transcript)
20
(No Transcript)
21
(No Transcript)
22
(No Transcript)
23
(No Transcript)
24
(No Transcript)
25
(No Transcript)
26
(No Transcript)
27
(No Transcript)
28
(No Transcript)
29
CMC Valvuloplasty(6-23-99----8-19-04)

• Aortic
  Complications
• 23 1 Perforation
• 1 Cardiac Arrest
• _________________________________________
• Mitral
• 37 1 Perforation
• _________________________________________
• Pulmonary
• 2 0